340 related articles for article (PubMed ID: 33347311)
1. Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication.
Zhang Y; Tang LV
J Proteome Res; 2021 Jan; 20(1):49-59. PubMed ID: 33347311
[TBL] [Abstract][Full Text] [Related]
2. Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CL
Mouffouk C; Mouffouk S; Mouffouk S; Hambaba L; Haba H
Eur J Pharmacol; 2021 Jan; 891():173759. PubMed ID: 33249077
[TBL] [Abstract][Full Text] [Related]
3. In silico study of the potential interactions of 4'-acetamidechalcones with protein targets in SARS-CoV-2.
Q Almeida-Neto FW; Castro Matos MG; Marinho EM; Marinho MM; Róseo Paula Pessoa Bezerra de Menezes R; Sampaio TL; Bandeira PN; Celedonio Fernandes CF; Magno Rodrigues Teixeira A; Marinho ES; de Lima-Neto P; Silva Dos Santos H
Biochem Biophys Res Commun; 2021 Jan; 537():71-77. PubMed ID: 33387885
[TBL] [Abstract][Full Text] [Related]
4. An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery.
Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA
Curr Top Med Chem; 2021; 21(7):571-596. PubMed ID: 33463470
[TBL] [Abstract][Full Text] [Related]
5. Structural insights of key enzymes into therapeutic intervention against SARS-CoV-2.
Shahid M; Shahzad-Ul-Hussan S
J Struct Biol; 2021 Mar; 213(1):107690. PubMed ID: 33383190
[TBL] [Abstract][Full Text] [Related]
6. Precision therapeutic targets for COVID-19.
Krumm ZA; Lloyd GM; Francis CP; Nasif LH; Mitchell DA; Golde TE; Giasson BI; Xia Y
Virol J; 2021 Mar; 18(1):66. PubMed ID: 33781287
[TBL] [Abstract][Full Text] [Related]
7. Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19.
Rajarshi K; Khan R; Singh MK; Ranjan T; Ray S; Ray S
Gene; 2021 Feb; 768():145313. PubMed ID: 33220345
[TBL] [Abstract][Full Text] [Related]
8. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
[TBL] [Abstract][Full Text] [Related]
9. Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19.
van de Leemput J; Han Z
Mol Cell Biol; 2021 Aug; 41(9):e0018521. PubMed ID: 34124934
[TBL] [Abstract][Full Text] [Related]
10. The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2.
Jin Z; Wang H; Duan Y; Yang H
Biochem Biophys Res Commun; 2021 Jan; 538():63-71. PubMed ID: 33288200
[TBL] [Abstract][Full Text] [Related]
11. Screening of Small-Molecule Libraries Using SARS-CoV-2-Derived Sequences Identifies Novel Furin Inhibitors.
Jorkesh A; Rothenberger S; Baldassar L; Grybaite B; Kavaliauskas P; Mickevicius V; Dettin M; Vascon F; Cendron L; Pasquato A
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791119
[TBL] [Abstract][Full Text] [Related]
12. Severe acute respiratory syndrome-coronavirus-2: Current advances in therapeutic targets and drug development.
Suganya S; Divya S; Parani M
Rev Med Virol; 2021 May; 31(3):e2174. PubMed ID: 32965078
[TBL] [Abstract][Full Text] [Related]
13. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
[TBL] [Abstract][Full Text] [Related]
14. Gold Metallodrugs to Target Coronavirus Proteins: Inhibitory Effects on the Spike-ACE2 Interaction and on PLpro Protease Activity by Auranofin and Gold Organometallics*.
Gil-Moles M; Basu U; Büssing R; Hoffmeister H; Türck S; Varchmin A; Ott I
Chemistry; 2020 Nov; 26(66):15140-15144. PubMed ID: 32915473
[TBL] [Abstract][Full Text] [Related]
15. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase.
Bertolin AP; Weissmann F; Zeng J; Posse V; Milligan JC; Canal B; Ulferts R; Wu M; Drury LS; Howell M; Beale R; Diffley JFX
Biochem J; 2021 Jul; 478(13):2425-2443. PubMed ID: 34198323
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry.
Shin YH; Jeong K; Lee J; Lee HJ; Yim J; Kim J; Kim S; Park SB
Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202115695. PubMed ID: 35043545
[TBL] [Abstract][Full Text] [Related]
17. Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion.
Kaur U; Chakrabarti SS; Ojha B; Pathak BK; Singh A; Saso L; Chakrabarti S
Curr Drug Targets; 2021; 22(2):192-201. PubMed ID: 32972339
[TBL] [Abstract][Full Text] [Related]
18. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
[TBL] [Abstract][Full Text] [Related]
19. Long-chain polyphosphates impair SARS-CoV-2 infection and replication.
Ferrucci V; Kong DY; Asadzadeh F; Marrone L; Boccia A; Siciliano R; Criscuolo G; Anastasio C; Quarantelli F; Comegna M; Pisano I; Passariello M; Iacobucci I; Monica RD; Izzo B; Cerino P; Fusco G; Viscardi M; Brandi S; Pierri BM; Borriello G; Tiberio C; Atripaldi L; Bianchi M; Paolella G; Capoluongo E; Castaldo G; Chiariotti L; Monti M; De Lorenzo C; Yun KS; Pascarella S; Cheong JH; Kim HY; Zollo M
Sci Signal; 2021 Jul; 14(690):. PubMed ID: 34230209
[TBL] [Abstract][Full Text] [Related]
20. An Overview of the Crystallized Structures of the SARS-CoV-2.
Ionescu MI
Protein J; 2020 Dec; 39(6):600-618. PubMed ID: 33098476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]